An Introduction to Testing for Drugs of Abuse. William E. Schreiber
Чтение книги онлайн.

Читать онлайн книгу An Introduction to Testing for Drugs of Abuse - William E. Schreiber страница 8

Название: An Introduction to Testing for Drugs of Abuse

Автор: William E. Schreiber

Издательство: John Wiley & Sons Limited

Жанр: Химия

Серия:

isbn: 9781119794073

isbn:

СКАЧАТЬ the United States.

      Source: Drug scheduling, United States Drug Enforcement Administration, www.dea.gov/drug‐scheduling.

Definition Examples
Schedule I
Drugs with no currently accepted medical use and a high potential for abuse Heroin
Marijuana (cannabis)
LSD peyote
MDMA
Schedule II
Drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence Cocaine
Methamphetamine
Methadone
Oxycodone
Fentanyl
Schedule III
Drugs with a moderate to low potential for physical and psychological dependence Codeine‐containing products (90 mg or less per dosage unit)
Ketamine
Anabolic steroids
Schedule IV
Drugs with a low potential for abuse and low risk of dependence Diazepam
Propoxyphene
Tramadol
Zolpidem
Schedule V
Drugs with lower potential for abuse than Schedule IV. These preparations contain limited quantities of certain narcotics and are generally used for antidiarrheal, antitussive, and analgesic purposes Cough preparations with codeine (200 mg or less per 100 mL)
Lomotil® (atropine/diphenoxylate)
Pregabalin

      LSD, lysergic acid diethylamide; MDMA, 3,4‐methylenedioxymethamphetamine (ecstasy).

      There are several fields of medicine in which drug testing is an essential part of diagnosis and monitoring.

       Emergency medicine – patients with an acute intoxication may present with aggressive or bizarre behavior or an altered level of consciousness. Testing for alcohols and other substances in blood helps the physician to identify the cause and monitor treatment. Screening for drugs in urine can identify recent consumption of commonly abused drugs and assist in follow‐up care.

       Addiction medicine – treatment of substance use disorders usually requires monitoring of patients for ongoing consumption of drugs. For example, patients on a methadone maintenance program are monitored to ensure that they are taking the methadone as prescribed and are not continuing to use other opioids. Treatment of alcohol use disorder includes testing for markers of alcohol consumption.

       Pain management – opioids and other medications are prescribed to treat chronic pain syndromes. Patients may sell or divert their medications, becoming distributors of pharmaceutical‐grade drugs to others who misuse them. Regular testing is performed to ensure compliance with the treatment program and to check for use of nonprescribed medications.

      Drug testing is also performed to promote safety in the workplace, support the legal system, and ensure fair competition in sports.

       Workplace drug testing – drug use among employees is responsible for time lost from work and increased numbers of job‐related accidents. Intoxicated employees are more likely to cause injury or death to themselves, their coworkers and innocent third parties. The transportation industry regularly tests drivers, pilots, and other workers for drug use to maintain standards of safety and accountability. Cut‐off concentrations for initial and confirmatory tests are published by the United States Department of Transportation (Table 1.2).

       Forensic toxicology – this term refers to drug analysis for legal purposes. Testing of drivers for ethanol and other drugs is used to establish intoxication, which may lead to arrest, prosecution, and civil or criminal penalties. People may be given drugs without their knowledge to incapacitate them for purposes of robbery or sex (drug‐facilitated assault). Analysis of the victim's blood or urine can identify such drugs. Toxicology is also a standard part of death investigations conducted by coroners and medical examiners. Postmortem analysis for drugs in blood, urine, and vitreous specimens is routinely performed to investigate a possible drug‐related cause of death.

       Performance enhancement – elite athletes, both professional and amateur, want a competitive edge, and some of them find it in performance‐enhancing drugs. These drugs are taken to improve strength and stamina and are different from recreational drugs of abuse. Examples include anabolic steroids, human growth hormone, and erythropoietin. Performance‐enhancing drugs are banned from major sporting competitions. The ban is enforced by testing athletes on a sporadic basis and immediately following competition.

      Source: United States Department of Transportation www.transportation.gov/odapc/part40/40‐87

Analyte Initial test Confirmatory test
Marijuana metabolite (THC‐COOH) 50 15
Cocaine metabolite (benzoylecgonine) 150 100
Codeine/morphine 2000 2000
Hydrocodone/hydromorphone 300 100
Oxycodone/oxymorphone 100 100
6‐Acetylmorphine 10 10
Phencyclidine 25 25
Amphetamine/methamphetamine СКАЧАТЬ